m 6A RNA Methylation Decreases Atherosclerotic Vulnerable Plaque Through Inducing T Cells حسب Chunmei Qi (739294)

"…<div><p>ABSTRACT Introduction: Knockdown of fat mass and obesity-associated gene (FTO) can induce N6-methyladenosine (m 6A) ribonucleic acid (RNA) methylation. …"

Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... حسب Ming-Ling Chang (44638)

"…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …"

Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... حسب Ming-Ling Chang (44638)

"…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …"

<i>clec-4(ok2050)</i> and <i>clec-4(ya1)</i> decrease <i>C</i>. <i>elegans</i> feeding leading to a reduced bacterial load. حسب Barbara Pees (3313560)

No change in muscle size and force, but a decrease in TB mass in 1-mo Lmna^HSA-cko mice. حسب Lei Xiong (334812)

Silencing of RCC1L isoforms alter the levels of mitochondrial ribosomal proteins and biogenesis factors resulting in decreased mitochondrial translation. حسب Aurelio Reyes (412135)

Fig 5 - حسب Thomas Jacquet (9960275)

Intraperitoneal hinokitiol injection does not decrease the number of live bacteria in BALF. حسب Toshihito Isono (8587668)

Umbelliprenin treatment decreases the activity of the TCF reporter in gastric cancer cells. حسب Lijing Zhang (463702)

Inflammatory cell infiltration in infected tissue is decreased in the AG treated group. حسب Mario C. Salinas-Carmona (9553084)

Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric <i>in silico</i> ROCOCO trial حسب Daniëlle B. P. Eekers (5560430)

ACT and ISO decrease pathological changes in LPS-induced AKI mice. حسب Jing Lian (1671991)

SUI-sEVs decreased the migration ability of primary cultured fibroblasts. حسب Xiaoyan Sun (28501)

rHSP60 decreases LPS-induced mononuclear cell proliferation. حسب Igor Emiliano L. Souza (18196495)

Placental aromatase expression decreased in severe neonatal opioid withdrawal syndrome حسب Courtney Townsel (6705368)

GTDE decreased the expression of the NLRP3 inflammasome and AGEs in the cerebral cortex. حسب Hui-Chuan Kuo (12368492)

Knockdown of MYC expression decreases sphere formation in pancreatic ductal cells. حسب Katsuhiko Sato (1767925)

Exposure to exogenous antioxidants prior to osmotic stress decreases tardigrade survival. حسب Amanda L. Smythers (9077730)

NatB-inactivation decreased Drk levels through its N-terminal sequences, which was regulated by the N-end rule E3 ubiquitin ligase POE/UBR4. حسب Zhentao Sheng (107495)

siRNA Knockdown of PKCδ decreases phosphorylation of VEEV capsid. حسب Brian D. Carey (6092747)